On April 4 in Orlando, Fla., a research team led by Dr. Harvey Pass discussed the results of a novel test used to detect pleural mesothelioma in its early stages. These researchers believe the incidence of pleural mesothelioma in the United States is approximately 3,000 new cases per year and is not expected to peak until about 2030.The test, “Multiplex SOMAmer Assay” by Somalogic Inc., uses SOMAmers, which are chemically modified single-stranded DNA molecules that specifically bind to proteins associated with pleural mesothelioma. Malignant mesothelioma, a rare and aggressive form of cancer, is most commonly found in the protective lining of the lungs, called the pleura.The major goal of the new diagnostic test is to detect pleural mesothelioma early enough to effectively treat it. ...
No comments:
Post a Comment